Kansas City Cancer Center-Shawnee Mission — Shawnee Mission, Kansas

Kansas City Cancer Center-Shawnee Mission is a clinical research site located in Shawnee Mission, Kansas, United States 66204.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Kansas City Cancer Center-Shawnee Mission has participated in 13 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer.

Sponsors: NSABP Foundation Inc, SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Shawnee Mission

Browse all research sites in Kansas · View every site in Shawnee Mission

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kansas City Cancer Center-Shawnee Mission?

Kansas City Cancer Center-Shawnee Mission has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kansas City Cancer Center-Shawnee Mission conducted?

Kansas City Cancer Center-Shawnee Mission has 13 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer.

Is Kansas City Cancer Center-Shawnee Mission accredited by Crixeo Clinical Trials?

Kansas City Cancer Center-Shawnee Mission has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kansas City Cancer Center-Shawnee Mission?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.